![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
[ Fri, Jan 31st 2014
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Thu, Jan 30th 2014
] - WOPRAI
[ Thu, Jan 30th 2014
] - WOPRAI
[ Thu, Jan 30th 2014
] - WOPRAI
[ Thu, Jan 30th 2014
] - WOPRAI
[ Thu, Jan 30th 2014
] - WOPRAI
[ Thu, Jan 30th 2014
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
[ Wed, Jan 29th 2014
] - WOPRAI
Rick Wise Maintained (BSX) at Strong Buy with Increased Target to $15 on, Jan 29th, 2014
Rick Wise of Stifel, Maintained "Boston Scientific Corporation" (BSX) at Strong Buy with Increased Target from $13 to $15 on, Jan 29th, 2014.
Rick has made no other calls on BSX in the last 4 months.
There are 3 other peers that have a rating on BSX. Out of the 3 peers that are also analyzing BSX, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Robbie Marcus of "JP Morgan" Maintained at Hold with Increased Target to $14 on, Tuesday, January 28th, 2014
These are the ratings of the 2 analyists that currently disagree with Rick
- Cecilia Furlong of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $15 on, Monday, January 6th, 2014
- Joshua Jennings of "Cowen & Co." Upgraded from Hold to Buy on, Friday, December 6th, 2013
Contributing Sources